Zydus Lifesciences has revised its share buyback plan by increasing the buyback price to Rs 1,260 per share while reducing the number of shares to be repurchased to 87.3 lakh from the previously announced 95.65 lakh. The buyback, which maintains a total outlay of up to Rs 1,100 crore, will be conducted through the tender offer route in accordance with SEBI regulations.
The pharmaceutical company had initially announced its buyback proposal on May 20, 2026. The revised buyback size now represents up to 0.87% of the company’s paid-up equity share capital. Today marked the last opportunity for investors to purchase shares to participate in the buyback, with the record date set for May 29.
Zydus Lifesciences has seen its shares rally by 19% over the past year, significantly outperforming the Nifty and BSE Sensex, which posted negative returns of 4% and 8%, respectively, over the same period. The company's strong financial performance, including a 9% increase in net profit to Rs 1,272.5 crore for the January-March quarter of FY26, has likely contributed to this positive market sentiment.
The company's revenue from operations also rose by more than 16% year-on-year, reaching Rs 7,587 crore during the quarter under review, compared to Rs 6,528 crore in the previous year. These robust financial results underscore Zydus Lifesciences' strong market position and growth trajectory.
Investors must adhere to SEBI's T+1 settlement norm, requiring them to purchase shares at least one trading day before the record date to ensure eligibility for the buyback. This ensures that shares are credited to their demat accounts by the record date.
Background
Zydus Lifesciences' strategic adjustment in its buyback plan reflects its commitment to enhancing shareholder value while navigating market dynamics. Investors will be closely watching the company's next moves and market performance as it continues to build on its recent successes.
Zydus Lifesciences' strategic adjustment in its buyback plan reflects its commitment to enhancing shareholder value while navigating market dynamics. Investors will be closely watching the company's next moves and market performance as it continues to build on its recent successes.
